Magnesium Supplementation: Formulation Selection and Dosing
Direct Recommendation
For general magnesium supplementation in adults with normal renal function, use magnesium glycinate 200–400 mg daily (taken at night), as it offers superior bioavailability with minimal gastrointestinal side effects. 1 If the patient has diarrhea, magnesium glycinate is strongly preferred over magnesium citrate or oxide because it causes significantly less osmotic diarrhea. 1
Formulation Selection Algorithm
Step 1: Assess Renal Function First
- Check creatinine clearance before prescribing any magnesium supplement. 1, 2
- Absolute contraindication: CrCl <20 mL/min—avoid all magnesium supplementation due to life-threatening hypermagnesemia risk. 1, 2, 3
- Caution zone: CrCl 20–30 mL/min—avoid unless life-threatening emergency (e.g., torsades de pointes), and only with close monitoring. 2
- Reduced dosing: CrCl 30–60 mL/min—use reduced doses with close monitoring. 2
Step 2: Choose Formulation Based on Clinical Context
For General Supplementation (No Constipation)
- First choice: Magnesium glycinate 200–400 mg daily, taken at night when intestinal transit is slowest to maximize absorption. 1, 2
- Alternative: Magnesium citrate 200–400 mg daily if glycinate unavailable. 1
- Rationale: Organic salts (glycinate, citrate, aspartate, lactate) have superior bioavailability compared to inorganic forms (oxide, hydroxide). 1
For Patients with Diarrhea or Loose Stools
- Strongly prefer magnesium glycinate because it causes minimal osmotic effect and less diarrhea. 1
- Avoid magnesium citrate and oxide in patients with diarrhea—both create strong osmotic gradients that worsen loose stools. 1
- Timing strategy: Take magnesium bisglycinate at night when intestinal transit is slower to enhance absorption before reaching the colon and reduce diarrhea risk. 1
For Chronic Constipation
- First choice: Magnesium oxide 400–500 mg daily, titrate up to 1,000–1,500 mg daily based on response. 2
- Alternative: Magnesium citrate for stronger osmotic effect if oxide insufficient. 1
- Cost consideration: Magnesium oxide costs <$50/month versus $374–$523 for prescription secretagogues. 2
- Mechanism: Both work osmotically by drawing water into the intestinal lumen to soften stool. 1, 2
Dosing Regimens
General Supplementation Dosing
- Starting dose: Begin at the Recommended Dietary Allowance (RDA)—320 mg/day for women, 420 mg/day for men. 1, 2
- Titration: Increase gradually according to tolerance; some patients require 600–6,500 mg daily for therapeutic effect. 1
- Administration: Spread doses throughout the day rather than single large dose to improve absorption and reduce GI side effects. 1
- Formulation preference: Liquid or dissolvable forms are better tolerated than pills. 1, 2
Constipation-Specific Dosing
- Magnesium oxide: Start 400–500 mg daily, titrate to 1,000–1,500 mg daily as needed. 2
- Magnesium citrate: 300 mL × 3 for bowel preparation; lower doses for chronic constipation. 1
- Clinical trial data: Magnesium oxide studied at 1.5 g/day for constipation, though 500–1,000 mg/day commonly used in practice. 1
Special Clinical Scenarios
- Short bowel syndrome: 12–24 mmol daily (480–960 mg elemental magnesium), preferably at night. 2
- Refractory hypomagnesemia: Add oral 1-alpha hydroxy-cholecalciferol 0.25–9.00 μg daily if oral magnesium fails, with calcium monitoring. 2
- Cardiac emergencies (torsades de pointes): 1–2 g IV magnesium sulfate over 5 minutes regardless of serum level. 2
Dose Adjustment for Renal Impairment
CrCl >60 mL/min
CrCl 30–60 mL/min
- Use reduced doses (start at 50% of standard dose). 2
- Monitor magnesium levels every 2–3 weeks initially, then monthly. 2
CrCl 20–30 mL/min
- Avoid unless life-threatening emergency. 2
- If absolutely necessary, use lowest possible dose with daily monitoring. 2
CrCl <20 mL/min or Dialysis
- Absolute contraindication—do not prescribe any oral magnesium supplement. 1, 2, 3
- For dialysis patients with constipation, use polyethylene glycol (PEG) 17 g daily as first-line (strong recommendation, moderate-quality evidence). 3
- Alternative constipation options: psyllium fiber, lactulose, bisacodyl, or sodium picosulfate. 3
Critical Safety Considerations
Hydration and Sodium Balance
- Ensure adequate hydration and sodium intake during magnesium supplementation—depletion of water and sodium provokes secondary hyperaldosteronism, which increases urinary magnesium loss and may necessitate higher oral doses. 1
- In patients with high GI losses or short bowel syndrome: Correct volume depletion with IV normal saline (2–4 L/day initially) before starting magnesium supplementation to eliminate secondary hyperaldosteronism. 2
Monitoring Timeline
- Baseline: Check serum magnesium, potassium, calcium, and renal function. 2
- Early follow-up (2–3 weeks): Recheck magnesium level after starting supplementation; assess for side effects (diarrhea, abdominal distension). 2
- After dose adjustment: Recheck levels 2–3 weeks following any change. 2
- Stable maintenance: Monitor magnesium levels every 3 months once dose is stable. 2
- High-risk patients (short bowel syndrome, high GI losses, renal disease, medications affecting magnesium): Monitor more frequently. 2
Common Adverse Effects
- Diarrhea, abdominal distension, bloating, nausea—most common with magnesium citrate and oxide due to osmotic properties. 1, 2
- Fecal magnesium >45 mmol/L strongly indicates magnesium-induced diarrhea. 1
- Management: Reduce dose, switch to magnesium glycinate, or take at night when transit is slower. 1
Common Pitfalls to Avoid
Never supplement magnesium without checking renal function first—hypermagnesemia in renal impairment can be fatal. 1, 2
Never attempt to correct hypokalemia or hypocalcemia before normalizing magnesium—these electrolyte abnormalities are refractory to supplementation until magnesium is corrected. 2
Never use magnesium citrate or oxide in patients with diarrhea—choose glycinate instead to avoid worsening osmotic diarrhea. 1
Never assume normal serum magnesium excludes deficiency—less than 1% of total body magnesium is in blood, so normal levels can coexist with significant intracellular depletion. 2
Never prescribe magnesium-containing laxatives (milk of magnesia, magnesium oxide) to dialysis patients—use PEG instead. 3
Never overlook volume depletion in patients with high GI losses—correct sodium and water depletion with IV saline first, or oral magnesium supplementation will fail due to ongoing renal magnesium wasting from secondary hyperaldosteronism. 2
Avoid magnesium hydroxide (milk of magnesia) in elderly patients—increased risk of hypermagnesemia and electrolyte disturbances. 3